Zhangchen Zhao

Dr. Zhangchen Zhao

The University of Michigan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
WZWei Zhou
Wei Zhou
ZZZhangchen Zhao
Zhangchen Zhao
JNJonas B. Nielsen
Jonas B. Nielsen
LFLars G. Fritsche
Lars G. Fritsche
JLJonathon LeFaive
Jonathon LeFaive
SLSeunggeun Lee
Seunggeun Lee

22 September 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WZWei Zhou
Wei Zhou
WBWenjian Bi
Wenjian Bi
ZZZhangchen Zhao
Zhangchen Zhao
KDKushal K. Dey
Kushal K. Dey
KJKarthik A. Jagadeesh
Karthik A. Jagadeesh
SLSeunggeun Lee
Seunggeun Lee
Several biobanks, including UK Biobank (UKBB), are generating large-scale sequencing data. An existing method, SAIGE-GENE, performs well when testing variants with minor allele frequency (MAF) ≤ 1%, but inflation is observed in variance component set-based tests when restricting to variants with MAF ≤ 0.1% or 0.01%. Here, we propose SAIGE-GENE+ with greatly improved type I error control and computational efficiency to facilitate rare variant tests in large-scale data. We further show that incorporating multiple MAF cutoffs and functional annotations can improve power and thus uncover new gene–phenotype associations. In the analysis of UKBB whole exome sequencing data for 30 quantitative and 141 binary traits, SAIGE-GENE+ identified 551 gene–phenotype associations.

26 September 2017 in Environmental Health
Verified
Journal Article
Open access
PDF file
SPSung Kyun Park
Sung Kyun Park
ZZZhangchen Zhao
Zhangchen Zhao
BMBhramar Mukherjee
Bhramar Mukherjee
There is growing concern of health effects of exposure to pollutant mixtures. We initially proposed an Environmental Risk Score (ERS) as a summary measure to examine the risk of exposure to multi-pollutants in epidemiologic research considering only pollutant main effects. We expand the ERS by consideration of pollutant-pollutant interactions using modern machine learning methods. We illustrate the multi-pollutant approaches to predicting a marker of oxidative stress (gamma-glutamyl transferase (GGT)), a common disease pathway linking environmental exposure and numerous health endpoints. We examined 20 metal biomarkers measured in urine or whole blood from 6 cycles of the National Health and Nutrition Examination Survey (NHANES 2003–2004 to 2013–2014, n = 9664). We randomly split the data evenly into training and testing sets and constructed ERS’s of metal mixtures for GGT using adaptive elastic-net with main effects and pairwise interactions (AENET-I), Bayesian additive regression tree (BART), Bayesian kernel machine regression (BKMR), and Super Learner in the training set and evaluated their performances in the testing set. We also evaluated the associations between GGT-ERS and cardiovascular endpoints. ERS based on AENET-I performed better than other approaches in terms of prediction errors in the testing set. Important metals identified in relation to GGT include cadmium (urine), dimethylarsonic acid, monomethylarsonic acid, cobalt, and barium. All ERS’s showed significant associations with systolic and diastolic blood pressure and hypertension. For hypertension, one SD increase in each ERS from AENET-I, BART and SuperLearner were associated with odds ratios of 1.26 (95% CI, 1.15, 1.38), 1.17 (1.09, 1.25), and 1.30 (1.20, 1.40), respectively. ERS’s showed non-significant positive associations with mortality outcomes. ERS is a useful tool for characterizing cumulative risk from pollutant mixtures, with accounting for statistical challenges such as high degrees of correlations and pollutant-pollutant interactions. ERS constructed for an intermediate marker like GGT is predictive of related disease endpoints.

13 October 2022 in The American Journal of Human Genetics
Verified
Journal Article
Open access
ZZZhangchen Zhao
Zhangchen Zhao
LFLars G. Fritsche
Lars G. Fritsche
JSJennifer A. Smith
Jennifer A. Smith
BMBhramar Mukherjee
Bhramar Mukherjee
SLSeunggeun Lee
Seunggeun Lee
As most existing genome-wide association studies (GWASs) were conducted in European-ancestry cohorts, and as the existing polygenic risk score (PRS) models have limited transferability across ancestry groups, PRS research on non-European-ancestry groups needs to make efficient use of available data until we attain large sample sizes across all ancestry groups. Here we propose a PRS method using transfer learning techniques. Our approach, TL-PRS, uses gradient descent to fine-tune the baseline PRS model from an ancestry group with large sample GWASs to the dataset of target ancestry. In our application of constructing PRS for seven quantitative and two dichotomous traits for 10,285 individuals of South Asian ancestry and 8,168 individuals of African ancestry in UK Biobank, TL-PRS using PRS-CS as a baseline method obtained 25% average relative improvement for South Asian samples and 29% for African samples compared to the standard PRS-CS method in terms of predicted R2. Our approach increases the transferability of PRSs across ancestries and thereby helps reduce existing inequities in genetics research.

11 July 2019 in bioRxiv
Verified
Preprint
Open access
ZZZhangchen Zhao
Zhangchen Zhao
WBWenjian Bi
Wenjian Bi
WZWei Zhou
Wei Zhou
PVPeter VandeHaar
Peter VandeHaar
LFLars G. Fritsche
Lars G. Fritsche
SLSeunggeun Lee
Seunggeun Lee
In biobank data analysis, most binary phenotypes have unbalanced case-control ratios, which can cause inflation of type I error rates. Recently, a saddlepoint approximation (SPA) based single variant test has been developed to provide an accurate and scalable method to test for associations of such phenotypes. For gene- or region-based multiple variant tests, a few methods exist which adjust for unbalanced case-control ratios; however, these methods are either less accurate when case-control ratios are extremely unbalanced or not scalable for large data analyses. To address these problems, we propose SKAT/SKAT-O type region-based tests, where the single-variant score statistic is calibrated based on SPA and Efficient Resampling (ER). Through simulation studies, we show that the proposed method provides well-calibrated p-values. In contrast, the unadjusted approach has greatly inflated type I error rates (90 times of exome-wide α =2.5×10 -6 ) when the case-control ratio is 1:99. Additionally, the proposed method has similar computation time as the unadjusted approaches and is scalable for large sample data. Our UK Biobank whole exome sequence data analysis of 45,596 unrelated European samples and 791 PheCode phenotypes identified 10 rare variant associations with p-value < 10 -7 , including the associations between JAK2 and myeloproliferative disease, TNC and large cell lymphoma and F11 and congenital coagulation defects. All analysis summary results are publicly available through a web-based visual server.

24 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZZZhangchen Zhao
Zhangchen Zhao
Stephen SalernoStephen Salerno
Stephen Salerno
XSXu Shi
Xu Shi
SLSeunggeun Lee
Seunggeun Lee
BMBhramar Mukherjee
Bhramar Mukherjee
LFLars G. Fritsche
Lars G. Fritsche
Testing for SARS-CoV-2 antibodies is commonly used to determine prior COVID-19 infections and to gauge levels of infection- or vaccine-induced immunity. Michigan Medicine, a primary regional health center, provided an ideal setting to understand serologic testing patterns over time. Between 27 April 2020 and 3 May 2021, characteristics for 10,416 individuals presenting for SARS-CoV-2 antibody tests (10,932 tests in total) were collected. Relative to the COVID-19 vaccine roll-out date, 14 December 2020, the data were split into a pre- (8026 individuals) and post-vaccine launch (2587 individuals) period and contrasted with untested individuals to identify factors associated with tested individuals and seropositivity. Exploratory analysis of vaccine-mediated seropositivity was performed in 347 fully vaccinated individuals. Predictors of tested individuals included age, sex, smoking, neighborhood variables, and pre-existing conditions. Seropositivity in the pre-vaccine launch period was 9.2% and increased to 46.7% in the post-vaccine launch period. In the pre-vaccine launch period, seropositivity was significantly associated with age (10 year; OR = 0.80 (0.73, 0.89)), ever-smoker status (0.49 (0.35, 0.67)), respiratory disease (4.38 (3.13, 6.12)), circulatory disease (2.09 (1.48, 2.96)), liver disease (2.06 (1.11, 3.84)), non-Hispanic Black race/ethnicity (2.18 (1.33, 3.58)), and population density (1.10 (1.03, 1.18)). Except for the latter two, these associations remained statistically significant in the post-vaccine launch period. The positivity rate of fully vaccinated individual was 296/347(85.3% (81.0%, 88.8%)).